Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8397 |
Intermediate Similarity |
NPD6635 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2896 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD2118 |
Approved |
0.7917 |
Intermediate Similarity |
NPD2119 |
Approved |
0.7848 |
Intermediate Similarity |
NPD6026 |
Approved |
0.7718 |
Intermediate Similarity |
NPD4030 |
Approved |
0.7718 |
Intermediate Similarity |
NPD4028 |
Approved |
0.7718 |
Intermediate Similarity |
NPD4029 |
Approved |
0.7718 |
Intermediate Similarity |
NPD3942 |
Approved |
0.7718 |
Intermediate Similarity |
NPD3944 |
Approved |
0.7688 |
Intermediate Similarity |
NPD4326 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD1627 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD3475 |
Approved |
0.7635 |
Intermediate Similarity |
NPD3476 |
Approved |
0.7628 |
Intermediate Similarity |
NPD7469 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD6446 |
Discontinued |
0.7609 |
Intermediate Similarity |
NPD4824 |
Approved |
0.7609 |
Intermediate Similarity |
NPD4823 |
Approved |
0.7582 |
Intermediate Similarity |
NPD4804 |
Approved |
0.7578 |
Intermediate Similarity |
NPD5541 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD4641 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD6454 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD4805 |
Approved |
0.7468 |
Intermediate Similarity |
NPD4702 |
Approved |
0.7468 |
Intermediate Similarity |
NPD4703 |
Approved |
0.7456 |
Intermediate Similarity |
NPD6375 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD2809 |
Approved |
0.7439 |
Intermediate Similarity |
NPD6771 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD4510 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD7233 |
Approved |
0.7429 |
Intermediate Similarity |
NPD7234 |
Approved |
0.7417 |
Intermediate Similarity |
NPD1995 |
Approved |
0.7417 |
Intermediate Similarity |
NPD1994 |
Approved |
0.7417 |
Intermediate Similarity |
NPD1993 |
Approved |
0.741 |
Intermediate Similarity |
NPD4174 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD6148 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD3583 |
Phase 2 |
0.7379 |
Intermediate Similarity |
NPD271 |
Approved |
0.7379 |
Intermediate Similarity |
NPD270 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD268 |
Approved |
0.7372 |
Intermediate Similarity |
NPD5020 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4779 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD2075 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2070 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2072 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2071 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2073 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2074 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2068 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2069 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5315 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD3717 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD5636 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD3323 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD3813 |
Approved |
0.7278 |
Intermediate Similarity |
NPD751 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2511 |
Approved |
0.7262 |
Intermediate Similarity |
NPD4638 |
Approved |
0.7262 |
Intermediate Similarity |
NPD4640 |
Approved |
0.7262 |
Intermediate Similarity |
NPD4639 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD5104 |
Approved |
0.7251 |
Intermediate Similarity |
NPD6044 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD4547 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD1270 |
Approved |
0.7246 |
Intermediate Similarity |
NPD2915 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD7401 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD4384 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD200 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD201 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD5965 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD3262 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4973 |
Approved |
0.7212 |
Intermediate Similarity |
NPD3433 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD5255 |
Approved |
0.7209 |
Intermediate Similarity |
NPD8123 |
Approved |
0.7209 |
Intermediate Similarity |
NPD8122 |
Approved |
0.72 |
Intermediate Similarity |
NPD991 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD992 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD3961 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD792 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7287 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD5862 |
Discovery |
0.7159 |
Intermediate Similarity |
NPD6241 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD2581 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2582 |
Approved |
0.7151 |
Intermediate Similarity |
NPD3238 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3385 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6363 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD9583 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5400 |
Approved |
0.7119 |
Intermediate Similarity |
NPD5809 |
Phase 3 |
0.711 |
Intermediate Similarity |
NPD2753 |
Discontinued |
0.7102 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD3929 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD5611 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD2141 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2140 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2142 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6281 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1598 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD5088 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD269 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD1918 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD2462 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD2465 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2466 |
Phase 3 |
0.7045 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD5975 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD8026 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD7564 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD9357 |
Approved |
0.7 |
Intermediate Similarity |
NPD2007 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD2580 |
Discontinued |
0.6983 |
Remote Similarity |
NPD8021 |
Approved |
0.6983 |
Remote Similarity |
NPD8020 |
Approved |
0.698 |
Remote Similarity |
NPD748 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD2012 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD4889 |
Approved |
0.6966 |
Remote Similarity |
NPD5075 |
Discontinued |
0.6962 |
Remote Similarity |
NPD203 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD1380 |
Discovery |
0.6961 |
Remote Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD4075 |
Phase 2 |
0.6952 |
Remote Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD715 |
Phase 3 |
0.6946 |
Remote Similarity |
NPD6497 |
Approved |
0.6944 |
Remote Similarity |
NPD7175 |
Phase 1 |
0.6941 |
Remote Similarity |
NPD5744 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD1722 |
Approved |
0.6936 |
Remote Similarity |
NPD750 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD7026 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD3505 |
Approved |
0.6914 |
Remote Similarity |
NPD4181 |
Approved |
0.6914 |
Remote Similarity |
NPD3506 |
Approved |
0.6902 |
Remote Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD5322 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD8408 |
Discontinued |
0.6886 |
Remote Similarity |
NPD2748 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD8129 |
Discovery |
0.6879 |
Remote Similarity |
NPD3609 |
Approved |
0.6879 |
Remote Similarity |
NPD272 |
Approved |
0.6879 |
Remote Similarity |
NPD3610 |
Approved |
0.6879 |
Remote Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD4079 |
Approved |
0.6875 |
Remote Similarity |
NPD4076 |
Approved |
0.6868 |
Remote Similarity |
NPD7434 |
Approved |
0.686 |
Remote Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD6471 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD5100 |
Phase 3 |
0.6857 |
Remote Similarity |
NPD7402 |
Clinical (unspecified phase) |
0.6854 |
Remote Similarity |
NPD6194 |
Discontinued |
0.6848 |
Remote Similarity |
NPD7618 |
Phase 3 |
0.6848 |
Remote Similarity |
NPD7913 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD7619 |
Phase 3 |
0.6845 |
Remote Similarity |
NPD8248 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD4550 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD2780 |
Approved |
0.6842 |
Remote Similarity |
NPD2719 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD2782 |
Approved |
0.6842 |
Remote Similarity |
NPD2720 |
Phase 1 |
0.6839 |
Remote Similarity |
NPD9206 |
Approved |
0.6839 |
Remote Similarity |
NPD9207 |
Approved |
0.6836 |
Remote Similarity |
NPD2479 |
Phase 3 |
0.6836 |
Remote Similarity |
NPD2481 |
Approved |
0.6835 |
Remote Similarity |
NPD206 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD5820 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD1382 |
Phase 2 |
0.6832 |
Remote Similarity |
NPD1383 |
Phase 3 |
0.6831 |
Remote Similarity |
NPD6665 |
Discontinued |
0.6829 |
Remote Similarity |
NPD1661 |
Suspended |
0.6828 |
Remote Similarity |
NPD7204 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD5358 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD2061 |
Approved |
0.6818 |
Remote Similarity |
NPD5751 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD768 |
Clinical (unspecified phase) |
0.6811 |
Remote Similarity |
NPD6226 |
Phase 3 |
0.6811 |
Remote Similarity |
NPD7061 |
Clinical (unspecified phase) |
0.6798 |
Remote Similarity |
NPD7414 |
Clinical (unspecified phase) |
0.6796 |
Remote Similarity |
NPD8431 |
Approved |
0.6796 |
Remote Similarity |
NPD7394 |
Phase 2 |
0.6795 |
Remote Similarity |
NPD9726 |
Discontinued |
0.679 |
Remote Similarity |
NPD1427 |
Clinical (unspecified phase) |
0.679 |
Remote Similarity |
NPD4637 |
Clinical (unspecified phase) |
0.679 |
Remote Similarity |
NPD2006 |
Phase 2 |
0.6788 |
Remote Similarity |
NPD2430 |
Phase 2 |
0.6788 |
Remote Similarity |
NPD1183 |
Approved |
0.6788 |
Remote Similarity |
NPD3100 |
Discontinued |
0.678 |
Remote Similarity |
NPD8036 |
Clinical (unspecified phase) |
0.678 |
Remote Similarity |
NPD6555 |
Clinical (unspecified phase) |
0.678 |
Remote Similarity |
NPD8037 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD7021 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD6664 |
Approved |
0.6774 |
Remote Similarity |
NPD3654 |
Approved |
0.6772 |
Remote Similarity |
NPD7187 |
Phase 2 |
0.677 |
Remote Similarity |
NPD1395 |
Clinical (unspecified phase) |
0.6766
|
Remote Similarity |
NPD3339 |
Approved |